J. Goldman & Co’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
J. Goldman & Co's AMGN Position: Q1 2026 in Review
J. Goldman & Co reduced its Amgen (AMGN) stake by 77% in Q1 2026, selling an estimated $12M and leaving 9,900 shares worth $3.48M. The position accounts for 0.1% of the portfolio, ranked #236.
J. Goldman & Co first reported a position in AMGN in Q2 2022 and has held it in 10 quarters since. The position peaked at $27.8M in Q3 2023. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- J. Goldman & Co held 9,900 shares of Amgen worth $3.48M as of Q1 2026.
- J. Goldman & Co sold 33,588 Amgen shares in Q1 2026, an estimated $12M.
- Amgen made up 0.1% of J. Goldman & Co's portfolio in Q1 2026, its #236 holding.
- J. Goldman & Co first reported a position in Amgen in Q2 2022 and has held it in 10 quarters since.
- J. Goldman & Co's Amgen position peaked at $27.8M in Q3 2023.
- 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on J. Goldman & Co's 13F filing for Q1 2026, filed 15 May 2026.